Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $1.59 Million - $1.96 Million
-15,636 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $11,250 - $13,802
-131 Reduced 0.83%
15,636 $1.63 Million
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $654 - $832
-9 Reduced 0.06%
15,767 $1.35 Million
Q2 2020

Aug 11, 2020

BUY
$48.02 - $79.04 $757,563 - $1.25 Million
15,776 New
15,776 $1.16 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.5B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.